Literature DB >> 28693263

Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma.

Tomohiko Kakizaki1, Hiromitsu Hatakeyama1, Yuji Nakamaru1, Dai Takagi1, Takatsugu Mizumachi1, Tomohiro Sakashita1, Satoshi Kano1, Akihiro Homma1, Satoshi Fukuda1.   

Abstract

Inverted papilloma (IP) is a benign tumor occurring in the nasal cavity and paranasal sinuses. It is reported that 5-15% of IPs undergo malignant transformation into squamous cell carcinoma (SCC), and the role of microRNAs (miRNA/miR) in this process remains to be elucidated. In the present study, whole miRNA profiles using samples of IP and SCC were investigated, in order to detect the function of miRNA in the carcinogenesis of IP. Samples from IPs (n=5) and SCC lesions (n=5), which arose from IPs, were used for miRNA analysis. A total of 200 miRNAs exhibited a >2-fold differential expression between IP and SCC. miR-296-3p was markedly upregulated in SCC with a 23-fold difference. Computational analysis indicated that miR-296-3p targeted PTEN, which regulates the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and PTEN is involved in the carcinogenesis of SCC. miR-296-3p directly regulated PTEN expression in head and neck cancer cells, with PTEN protein levels decreased in 4/19 the SCCs (21.0%), as compared with those in the IPs (76.4%). Positive p21 staining was observed in 64.7% of IPs; this was a significantly increased rate compared with that for SCCs (26.3%, P=0.0086). The results of the present study indicated that there were marked changes in the miRNA expression signature during the malignant transition. miR-296-3p may serve an important role in the malignant transformation of IPs via the regulation of PTEN, combined with the subsequent inhibition of the PI3K/Akt signaling pathway, and may be a novel agent for cancer prevention.

Entities:  

Keywords:  malignant transformation; microRNA 296-3p; phosphatase and tensin homolog; sinonasal inverted papilloma

Year:  2017        PMID: 28693263      PMCID: PMC5494725          DOI: 10.3892/ol.2017.6193

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Pattern of expression of cell cycle-related proteins in malignant transformation of sinonasal inverted papilloma.

Authors:  Sun-Gui Kim; O-Young Lee; Jin-Woong Choi; Yong-Ho Park; Yong-Min Kim; Min-Kyung Yeo; Jin-Man Kim; Ki-Sang Rha
Journal:  Am J Rhinol Allergy       Date:  2011 Mar-Apr       Impact factor: 2.467

2.  The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.

Authors:  Liu Hong; Yu Han; Hongwei Zhang; Mengbin Li; Taiqian Gong; Li Sun; Kaichun Wu; Qingchuan Zhao; Daiming Fan
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

3.  Preservation of the nasolacrimal duct during endoscopic medial maxillectomy for sinonasal inverted papilloma.

Authors:  Yuji Nakamaru; Yasushi Furuta; Dai Takagi; Nobuhiko Oridate; Satoshi Fukuda
Journal:  Rhinology       Date:  2010-12       Impact factor: 3.681

4.  Regulation of PTEN transcription by p53.

Authors:  V Stambolic; D MacPherson; D Sas; Y Lin; B Snow; Y Jang; S Benchimol; T W Mak
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

Review 5.  Detection of human papillomavirus in sinonasal carcinoma: systematic review and meta-analysis.

Authors:  Kari Syrjänen; Stina Syrjänen
Journal:  Hum Pathol       Date:  2012-12-17       Impact factor: 3.466

6.  Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses.

Authors:  Y Furuta; T Shinohara; K Sano; K Nagashima; K Inoue; K Tanaka; Y Inuyama
Journal:  Laryngoscope       Date:  1991-01       Impact factor: 3.325

7.  PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

Authors:  Yoichi Nagata; Keng-Hsueh Lan; Xiaoyan Zhou; Ming Tan; Francisco J Esteva; Aysegul A Sahin; Kristine S Klos; Ping Li; Brett P Monia; Nina T Nguyen; Gabriel N Hortobagyi; Mien-Chie Hung; Dihua Yu
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

8.  Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma.

Authors:  Hiromitsu Hatakeyama; Haixia Cheng; Pamela Wirth; Ashley Counsell; Samuel R Marcrom; Carey Burton Wood; Paula R Pohlmann; Jill Gilbert; Barbara Murphy; Wendell G Yarbrough; Deric L Wheeler; Paul M Harari; Yan Guo; Yu Shyr; Robbert J Slebos; Christine H Chung
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

9.  Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma.

Authors:  Juana Maria Garcia Pedrero; Dario Garcia Carracedo; Cristina Muñoz Pinto; Agustín Herrero Zapatero; Juan Pablo Rodrigo; Carlos Suarez Nieto; Maria Victoria Gonzalez
Journal:  Int J Cancer       Date:  2005-03-20       Impact factor: 7.396

10.  MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region.

Authors:  A-rum Yoon; Ran Gao; Zeenia Kaul; Il-Kyu Choi; Jihoon Ryu; Jane R Noble; Yoshio Kato; Soichiro Saito; Takashi Hirano; Tetsuro Ishii; Roger R Reddel; Chae-Ok Yun; Sunil C Kaul; Renu Wadhwa
Journal:  Nucleic Acids Res       Date:  2011-06-30       Impact factor: 16.971

View more
  7 in total

Review 1.  Etiology of sinonasal inverted papilloma: An update.

Authors:  Pranit R Sunkara; Anirudh Saraswathula; Murugappan Ramanathan
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-08-24

Review 2.  Sinonasal Inverted Papilloma and Squamous Cell Carcinoma: Contemporary Management and Patient Outcomes.

Authors:  Jacob G Eide; Kevin C Welch; Nithin D Adappa; James N Palmer; Charles C L Tong
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

Review 3.  The Complex Landscape of PTEN mRNA Regulation.

Authors:  Erin Sellars; Martino Gabra; Leonardo Salmena
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

Review 4.  MicroRNA-296: a promising target in the pathogenesis of atherosclerosis?

Authors:  Heng Li; Xin-Ping Ouyang; Ting Jiang; Xi-Long Zheng; Ping-Ping He; Guo-Jun Zhao
Journal:  Mol Med       Date:  2018-03-26       Impact factor: 6.354

5.  Clinical evidence based review and systematic scientific review in the identification of malignant transformation of inverted papilloma.

Authors:  Cai Long; Basel Jabarin; Alexandra Harvey; Jennifer Ham; Amin Javer; Arif Janjua; Andrew Thamboo
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-04-30

6.  Comprehensive Analysis of Sinonasal Inverted Papilloma Expression Profiles Identifies Long Non-Coding RNA AKTIP as a Potential Biomarker.

Authors:  Hanyi He; Xinlu Wang; Yueyue Lu; Xiaojiang Lin; Yuandong Li; Yong Li; Zhihong Lin; Zhiqi Ma; Xiaolin Cao; Yaoshu Teng
Journal:  Front Genet       Date:  2022-02-02       Impact factor: 4.599

7.  3'UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signaling.

Authors:  Jinjin Yuan; Ziheng Feng; Qiaowen Wang; Lifen Han; Shenchan Guan; Lijuan Liu; Hanhui Ye; Lili Xu; Xiao Han
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.